The role of intestinal microflora in anti-inflammatory effect of baicalin in mice

Biomolecules and Therapeutics

Volumn 20, Issue 1, 2012, Pages 36-42

  Jung, Myung Ah ^a   Jang, Se Eun ^a   Hong, Sung Woon ^a   Hana, Myung Joo ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Baicalein; Baicalin; Inflammation; Metabolism; Oroxylin A; Scutellaria baicalensis

Indexed keywords

BAICALEIN; BAICALIN; BETA GLUCOSIDASE; BETA GLUCURONIDASE; CEFADROXIL; ERYTHROMYCIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OROXYLIN A; OXYTETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; HUMAN; INFLAMMATION; INTESTINE FLORA; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PERITONEUM MACROPHAGE; SCUTELLARIA BAICALENSIS;

EID: 84863145866     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2012.20.1.036     Document Type: Article

References (33)

1. Abe, K., Inoue, O. and Yumioka, E. (1990) Biliary excretion of metabolites of baicalin and baicalein in rats. Chem. Pharm. Bull. (Tokyo). 38, 209-211.
2. Akao, T., Kida, H., Kanaoka, M., Hattori, M. and Kobashi, K. (1988) Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 50, 1155-1160.
3. Akao, T., Kanaoka, M. and Kobashi, K. (1988) Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration--measurement of compound K by enzyme immunoassay. Biol. Pharm. Bull. 21, 245-249.
4. Akao, T., Sakashita, Y., Hanada, M., Goto, H., Shimada, Y. and Terasawa, K. (2004) Enteric excretion of baicalein, a flavone of Scutellariae Radix, via glucuronidation in rat: involvement of multidrug resistance-associated protein 2. Pharm. Res. 21, 2120-2126.
5. Akao, T., Kawabata, K., Yanagisawa, E., Ishihara, K., Mizuhara, Y., Wakui, Y., Sakashita, Y. and Kobashi, K. (2000) Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J. Pharm. Pharmacol. 52, 1563-1568.
6. Baldwin, A. S. Jr. (2001) Series introduction: the transcription factor NF-κB and human disease. J. Clin. Invest. 107, 3-6.
7. Chen, Y., Yang, L. and Lee, T. J. (2000) Oroxylin A inhibition of lipopolysaccharide- induced iNOS and COX-2 gene expression via suppression of nuclear factor-κB activation. Biochem. Pharmacol. 59, 1445-1457.
8. Choi, J. R., Hong, S. W., Kim, Y., Jang, S. E., Kim, N. J., Han, M. J. and Kim, D. H. (2011) Metabolic activities of ginseng and its constituents, ginsenoside Rb1 and Rg1, by human intestinal microflora. J. Ginseng. Res. 35, 301-307.
9. Chou, T. C., Chang, L. P., Li, C. Y., Wong, C. S. and Yang, S. P. (2003) The antiinflammatory and analgesic effects of baicalin in carrageenan-evoked thermal hyperalgesia. Anesth. Analg. 97, 1724-1729.
10. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D. and Maniatis, T. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9, 899-909.
11. Davis, P. A., Polagruto, J. A., Valacchi, G, Phung, A., Soucek, K., Keen, C. L. and Gershwin, M. E. (2006) Effect of apple extracts on NF-κB activation in human umbilical vein endothelial cells. Exp. Biol. Med. (Maywood). 231, 594-598.
12. Fairweather, D. and Rose, N. R. (2005) Inflammatory heart disease: a role for cytokines. Lupus. 14, 646-651.
13. Jang, S. I., Kim, H. J., Hwang, K. M., Jekal, S. J., Pae, H. O., Choi, B. M., Yun, Y. G., Kwon, T. O., Chung, H. T. and Kim, Y. C. (2003) Hepatoprotective effect of baicalin, a major flavone from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol. Immunotoxicol. 25, 585-594.
14. Joh, E. H., Lee, I. A., Jung, I. H. and Kim, D. H. (2011) Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-the key step of inflammation. Biochem. Pharmacol. 82, 278-286.
15. Joh, E. H. and Kim, D. H. (2011) Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways. Br. J. Pharmacol. 162, 1731-1742.
16. Kim, D. H. (2002) Herbal medicines are activated by intestinal microflora. Nat. Prod. Sci. 8, 35-43.
17. Kim, D. H., Cho, K. H., Moon, S. K., Kim, Y. S., Kim, D. H., Choi, J. S. and Chung, H. Y. (2005) Cytoprotective mechanism of baicalin against endothelial cell damage by peroxynitrite. J. Pharm. Pharmacol. 57, 1581-1590.
18. Kobashi, K. and Akao, T. (1997) Relation of intestinal bacteria to pharmacological effects of glycosides. Biosci. Microflora. 16, 1-7.
19. Lin, C. C. and Shieh, D. E. (1996) The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am. J. Chin. Med. 24, 31-36.
20. Lu, T., Song, J., Huang, F., Deng, Y., Xie, L., Wang, G. and Liu, X. (2007) Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix scutellariae extract and Huang- Lian-Jie-Du-Tang to rats. J. Ethnopharmacol. 110, 412-418.
21. Odashima, S., Ohta, T., Kohno, H., Matsuda, T., Kitagawa, I., Abe, H. and Arichi, S. (1985) Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer. Res. 45, 2781-2784.
22. O'Keefe, J. H., Gheewala, N. M. and O'Keefe, J. O. (2008) Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J. Am. Coll. Cardiol. 51, 249-255.
23. Paradkar, P. N., Blum, P. S., Berhow, M. A., Baumann, H. and Kuo, S. M. (2004) Dietary isoflavones suppress endotoxin-induced inflammatory reaction in liver and intestine. Cancer. Lett. 215, 21-28.
24. Shin, Y. W., Bae, E. A., Kim, S. S., Lee, Y. C. and Kim, D. H. (2005) Effect of ginsenoside Rb1 and compound K in chronic oxazoloneinduced mouse dermatitis. Int. Immunopharmacol. 5, 1183-1191.
25. Takido, M., Aimi, M., Takahashi, S., Yamanouchi, S. and Torii, H. (1995) Studies on the constituents in the water extracts of crude drugs. I. On the roots of Scutellaria baicalensis Georgi (Wōgon) (1) (author's transl). Yakugaku. Zasshi. 95, 108-113.
26. Trinh, H. T., Joh, E. H., Kwak, H. Y., Baek, N. I. and Kim, D. H. (2010) Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin A, in mice. Acta. Pharmacol. Sin. 31, 718-724.
27. Wakabayashi, C., Hasegawa, H., Murata, J. and Saiki, I. (1989) In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol. Res. 9, 411-417.
28. Wu, S., Sun, A. and Liu, R. (2005) Separation and purification of baicalin and wogonoside from the Chinese medicinal plant Scutellaria baicalensis Georgi by high-speed counter-current chromatography. J. Chromatogr. A. 1066, 243-247.
29. Xing, J., Chen, X. and Zhong, D. Absorption and enterohepatic circulation of baicalin in rats. Life. Sci. 78, 140-146.
30. Xing, J., Chen, X., Sun, Y., Luan, Y. and Zhong, D. (2005) Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. J. Pharm. Pharmacol. 57, 743-750.
31. Yang, J. H., Yun, M. Y., Lee, N. H., Kim, D. K., Kim, Y. I., Noh, Y. H., Kim, T. Y., Yoon, S. W. and Shin, S. C. (2008) The effects of ketorolac tromethamine and baicalein on the levels of inflammatory factors in human synoviocytes. Arch. Pharm. Res. 31, 1517-1523.
32. Yim, J. S., Kim, Y. S., Moon, S. K., Cho, K. H., Bae, H. S., Kim, J. J., Park, E. K. and Kim, D. H. (2004) Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol. Pharm. Bull. 27, 1580-1583.
33. Zhu, Y. P. (1998) Chinese Materia Medica. Harwood academic publichers, Australia. 127-135.